OncoSec Medical Inc (ONCSQ)

[guti]

there was a clinical hold of an investigational agent, which lasted two months, I had forgotten the correct information, thank you. What I am trying to refer to is on this article posted in 2016. https://www.statnews.com/2016/08/22/advaxis-amgen-cancer-listeria/

"But in October 2015, the FDA forced Advaxis to halt four trials of AXAL after a patient with end-stage cervical cancer who died of her disease was found to have listeria in her bloodstream. The stock plummeted.
Advaxis submitted a new plan to the FDA, which included administering antibiotics to patients after treatment. Two months later, the FDA lifted the clinical hold.
Advaxis is now recruiting for Phase 3 trials."